Latest Comments on Michael Becker's Articles

1. S Thorwald Olsson on 13 Biotechs to Watch for at Hematology Conference: I print direct on the line and with the spell control on it should... more »
2. S Thorwald Olsson on 13 Biotechs to Watch for at Hematology Conference: I just want to give you my strong bye-recommendation as a final:... more »
3. S Thorwald Olsson on 13 Biotechs to Watch for at Hematology Conference: I want to thank you for an outstanding straight and informative... more »
4. jimmy Turano on Three Recent Biotech Activist Wins by Carl Icahn: HAPPY THANKSGIVING MIKE BECKER. I THOUGHT SOMEHOW, I COULD REACH... more »
5. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: A comprehensive review of the Parkinson's disease therapeutic... more »
6. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Thank you. Unfortunately, we did not perform the currency... more »
7. Vitautas on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Mr. Becker! Why you don't mentioned Newron Pharma when you talk... more »
8. maxiedog on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Check your UK pence to USD calculation. 10p is £0.1 not £1. more »
9. 414555 on Healthcare Reform vs Innovation and Growth?: Myth: Police and firefighters retire at age 50 with 90 percent of... more »
10. 414555 on Healthcare Reform vs Innovation and Growth?: Myth: Government pensions are paid by taxpayers. September 23,... more »
11. 414555 on Healthcare Reform vs Innovation and Growth?: > The real waste is retirement of government employees after 30... more »
12. rrbatch on Healthcare Reform vs Innovation and Growth?: I fully agree with the contention that innovation in medicines and... more »
13. advalorem on 11 Ache-Free Investment Opportunities in Neuropathic Pain: Michael, terrific article. Thank you. more »
14. biopharmabull on Bayer's Bold New Bet Fails to Rain on Spectrum Pharma: There is really only one reason for the commercial failure of... more »
15. Michael Becker on Bayer's Bold New Bet Fails to Rain on Spectrum Pharma: Actually, what is making news (and hence, the topic of the... more »